Comparison of targeted next generation sequencing assays in non-small cell lung cancer patients

Abstract Non-small cell lung cancer (NSCLC) is the most prevalent type of lung cancer the mutational spectrum of which has been extensively characterized. Treatment of patients with NSCLC based on their molecular profile is now part of the standard clinical care. The aim of this study was firstly to...

Full description

Bibliographic Details
Published in:Discover Oncology
Main Authors: Ieva Drejeriene, Jurate Gruode, Saulius Cicenas, Charalambos Loizides, Alexia Eliades, Achilleas Achilleos, Elena Kypri, Kyriakos Tsangaras, Marios Ioannides, George Koumbaris, Diana Stanciute, Arnoldas Krasauskas, Philippos C. Patsalis
Format: Article
Language:English
Published: Springer 2024-12-01
Subjects:
NSCLC
mutational profile
clinical utility
next generation sequencing
Online Access:https://doi.org/10.1007/s12672-024-01640-7

Internet

https://doi.org/10.1007/s12672-024-01640-7

Similar Items